EORTC Medical Director Dr Vassilis Golfinopoulos talks about the aims of SPECTA
1 Dec 2014
Hear EORTC Medical Director Dr Vassilis Golfinopoulos talk about the aims of SPECTA (Screening Patients for Efficient Clinical Trial Access) and catch up on other news from 26th EORTC – NCI – AACR symposium on molecular targets in cancer therapeutics in Barcelona.
Related News
First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer
28 Oct 2026
EORTC at ESMO 2026: New findings and ongoing studies
27 Oct 2026
EORTC research presented at ESMO 2026
22 Oct 2026
EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
Final results of ARCAGEN – An EORTC-SPECTA and EURACAN initiative for molecular profiling and access to treatment for rare cancers
23 Jul 2026
